Cortagen vs Dihexa
A side-by-side research comparison of Cortagen and Dihexa across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Cortagen | Dihexa |
|---|---|---|
| Full name | Cortagen (Brain Cortex Peptide) | Dihexa (N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide) |
| Category | Cognitive & Nootropic | Cognitive & Nootropic |
| Status | Research compound | Research compound |
| Mechanism | Regulates gene expression in cerebral cortex neurons, modulating neurotransmitter receptor density, synaptic plasticity, and neuronal energy metabolism. | Allosteric potentiator of HGF/c-Met signaling driving synaptogenesis, dendritic spine formation, and neuronal survival in hippocampal circuits. |
| Molecular weight | ~420 Da | 507.6 Da |
| Half-life | ~2-4 hours | 6-12 hours |
| Bioavailability | ~70% oral (as capsule); ~85% subcutaneous | Moderate (oral/SubQ) |
| Typical dose | 10 mg | 10-20 mg (oral) or 2-5 mg (SubQ) |
| Frequency | Daily for 10-15 days | Daily |
| Route | Oral capsule or subcutaneous injection | Oral or Subcutaneous |
Cortagen reported benefits
- Cerebral cortex optimization
- Cognitive function improvement
- Memory enhancement
- Neuroprotection
Dihexa reported benefits
- Dramatic synaptogenesis
- Memory improvement
- Cognitive restoration potential
- Dendritic spine growth
- HGF/c-Met activation
Related comparisons
Research and educational reference only. Not medical advice.